| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10683 | 2021 |
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ... Nature medicine 15 (10), 1170-1178, 2009 | 2018 | 2009 |
| Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice M Michaud, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, ... Science 334 (6062), 1573-1577, 2011 | 1390 | 2011 |
| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 1017 | 2014 |
| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 831 | 2014 |
| Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells Y Ma, S Adjemian, SR Mattarollo, T Yamazaki, L Aymeric, H Yang, ... Immunity 38 (4), 729-741, 2013 | 694 | 2013 |
| The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies L Zitvogel, Y Ma, D Raoult, G Kroemer, TF Gajewski Science 359 (6382), 1366-1370, 2018 | 634 | 2018 |
| Molecular mechanisms of ATP secretion during immunogenic cell death I Martins, Y Wang, M Michaud, Y Ma, AQ Sukkurwala, S Shen, O Kepp, ... Cell Death & Differentiation 21 (1), 79-91, 2014 | 491 | 2014 |
| Autophagy and cellular immune responses Y Ma, L Galluzzi, L Zitvogel, G Kroemer Immunity 39 (2), 211-227, 2013 | 443 | 2013 |
| A dual role for autophagy in a murine model of lung cancer S Rao, L Tortola, T Perlot, G Wirnsberger, M Novatchkova, R Nitsch, ... Nature communications 5 (1), 3056, 2014 | 434 | 2014 |
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 431 | 2015 |
| Cardiac glycosides exert anticancer effects by inducing immunogenic cell death L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, S Shen, T Yamazaki, ... Science translational medicine 4 (143), 143ra99-143ra99, 2012 | 418 | 2012 |
| Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy Y Ma, L Aymeric, C Locher, SR Mattarollo, NF Delahaye, P Pereira, ... Journal of Experimental Medicine 208 (3), 491-503, 2011 | 389 | 2011 |
| Tumor microenvironment‐activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade F Zhou, B Feng, H Yu, D Wang, T Wang, Y Ma, S Wang, Y Li Advanced Materials 31 (14), 1805888, 2019 | 385 | 2019 |
| Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment B Feng, F Zhou, B Hou, D Wang, T Wang, Y Fu, Y Ma, H Yu, Y Li Advanced materials 30 (38), 1803001, 2018 | 372 | 2018 |
| Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors SR Mattarollo, S Loi, H Duret, Y Ma, L Zitvogel, MJ Smyth Cancer research 71 (14), 4809-4820, 2011 | 365 | 2011 |
| Trial watch: Prognostic and predictive value of the immune infiltrate in cancer L Senovilla, E Vacchelli, J Galon, S Adjemian, A Eggermont, WH Fridman, ... Oncoimmunology 1 (8), 1323-1343, 2012 | 281 | 2012 |
| Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 233 | 2019 |
| Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity H Yang, L Xia, J Chen, S Zhang, V Martin, Q Li, S Lin, J Chen, J Calmette, ... Nature medicine 25 (9), 1428-1441, 2019 | 220 | 2019 |
| Chemotherapy and radiotherapy: cryptic anticancer vaccines Y Ma, O Kepp, F Ghiringhelli, L Apetoh, L Aymeric, C Locher, A Tesniere, ... Seminars in immunology 22 (3), 113-124, 2010 | 206 | 2010 |
